ANAyaka Nakai

Ayaka Nakai

*This is an algorithmically generated author record based on publicly available information.

Ayaka Nakai has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chiho Shoda

    Laboratory of Photobiology, Keio University School of Medicine, Tokyo 160-8582, Japan

    1 shared publication
  • Corina N. D’alessandoro-Gabazza

    Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan

    1 shared publication
  • Deokho Lee

    The Korean Institute of Nutrition, Hallym University, 1 Hallymdeahak-Gil, Chuncheon 24252, Republic of Korea

    1 shared publication
  • Esteban Cesar Gabazza

    Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan

    1 shared publication
  • Hirofumi Hirai

    Faculty of Global Interdisciplinary Science and Innovation, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan; Research Institute for Mushroom Science, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan; Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan; Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan

    1 shared publication
  • Hirokazu Kawagishi

    Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka 422-8529, Japan

    1 shared publication

Latest Publications

  • Open Access

    Axl, Immune Checkpoint Molecules and HIF Inhibitors from the Culture Broth of Lepista luscina

    by Mihaya Kotajima, Jae-Hoon Choi, Mitsuru Kondo, Corina N. D’alessandro-Gabazza, Masaaki Toda, Taro Yasuma, Esteban C. Gabazza, Yukihiro Miwa, Chiho Shoda, Deokho Lee, et al.

    Two compounds 1 and 2 were isolated from the culture broth of Lepista luscina. This is the first time that compound 1 was isolated from a natural source. The structure of compound 1 was identified via 1D and 2D NMR and HRESIMS data. Compounds 1 and 2 along with 8-nitrotryptanthrin (4) were evaluated for their biological activities using the A549 lung cancer cell line. As a result, 1 and 2 inhibited the expression of Axl and immune checkpoint molecules. In addition, compounds 1, 2 and 4 were tested for HIF inhibitory activity. Compound 2 demonstrated statistically significant HIF inhibitory effects on NIH3T3 cells and 1 and 2 against ARPE19 cells.